跳至主要内容
临床试验/NL-OMON50001
NL-OMON50001已完成不适用

Carotid body dysfunction in type 2 diabetes - Carotid body function in T2DM

eids Universitair Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18 years and older
  • Non insulin dependent DM
  • No medical disease
  • Vital signs within specific boundries
  • Healthy apart from their DM
  • \See page 13 of the protocol

排除标准

  • * Insulin dependent diabetes mellitus
  • * Diagnosed Obstructive Sleep Apnea (OSAS) or high suspicion of OSAS determined
  • by a STOP-BANG score > 5
  • * Respiratory or cardiovascular disease
  • * Smoking/vaping
  • * Positive pregnancy test
  • * conditions that result in elevated levels of methaemoglobinia
  • * body mass index > 35 kg/m2
  • * Use of illicit drugs
  • * Use of prescription opioids or benzodiazepines
  • * Failure of the drug of abuse tests at screening or check-in.
  • * History of dyspnea, asthma, tuberculosis, chronic obstructive pulmonary
  • disease, or any other ventilatory / lung disease.
  • * Subjects with excessive facial hair preventing sealing of the occlusive face
  • * Subjects who, in the opinion of the investigator, will not be able to
  • participate optimally in the study.
  • * Subject who has a history of any infectious disease within 4 weeks prior to
  • drug administration that in the opinion of the investigator, affects the
  • subject*s ability to participate in the trial.
  • * Subjects who are part of the study staff personnel or family members of the
  • study staff personnel.
  • * Subjects who have demonstrated allergic reactions (e.g., food, drug, atopic
  • reactions or asthmatic episodes) which, in the opinion of the investigator and
  • sponsor, interfere with their ability to participate in the trial.
  • * Personal or family history of arrhythmias or ECG conductance abnormalities.
  • * Hypokalemia defined as <3.5 mmol/L

研究者

相似试验